Latest News
21-Nov-2024 ‘About 18% of Deaths in 2019 Attributable to Air Pollution’
20-Nov-2024 High Pollution May Boost Demand for Respiratory Drugs
13-Nov-2024 Pharma Market Sees 6.1% Growth in Oct Despite Subdued Volumes
08-Nov-2024 Biocon Biologics Looking to Pare $300m Acquisition Debt
07-Nov-2024 NPPA asks Cos to Cut Prices of 3 Cancer Drugs Post Tax Relief
  more...
Latest Reports
Oct-24 Steady Q2; Revlimid to normalise - HDFC Securities  
Oct-24 Q2FY25 preview: Seasonality to boost volumes - ICICI Securities  
Oct-24 Domestic Formulations Strengthen Amid U.S. Generics... - Sharekhan  
Oct-24 Healthy quarter in the offing - Emkay Research  
Oct-24 Strong quarter aided by US sales & higher margins - Prabhudas Lilladher  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 22 Nov 2024
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 431346.15
Divi's Lab 159254.07
Cipla 120033.59
Torrent Phar 107304.09
Mankind Phar 102215.09
Dr.Reddy's 101287.82
Zydus Life 95458.19
Lupin 94420.77
Aurobindo Ph 71693.65
Alkem Labora 66612.66
Abbott (I) 58861.86
Glenmark Pha 41767.01
GlaxoSmith.P 40915.90
  click here for the complete list